(Q27487377)
Statements
Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity (English)
0 references
November 2008
0 references
79
0 references
5
0 references
678-84
0 references